Top Markets
Coin of the day
Original BioMedicals Co., Ltd. Original BioMedicals Co., Ltd.

Original BioMedicals Co., Ltd.

6483
Classement en actions #27912
Original BioMedicals Co., Ltd. is a biotechnology company focused on creating... Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.
Prix de l'action
$0.44677634
Capitalisation boursière
$29.85M
Changement (1 jour)
0.36%
Changement (1 an)
-2.97%
Pays
TW
Échange Original BioMedicals Co., Ltd. (6483)

Catégorie

Ratio P/S pour Original BioMedicals Co., Ltd. (6483)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Original BioMedicals Co., Ltd., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Original BioMedicals Co., Ltd. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes